Champions Oncology, Inc. (CSBR) stock
CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30238% above fair value
$4.59−0.09 (-1.89%)
Close on Nov 17, 2026Market cap $63.91MP/E –Yield –
Champions Oncology market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Champions Oncology's market cap was $66.53M on Nov 11, 2026, against $90.18M a year earlier. Over the last 5 years it ranged from $53.15M to $150.55M, with a median of $83.74M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $66.53M | -30.7% |
| 2025 | Dec 31, 2025 | $95.95M | -18.3% |
| 2024 | Dec 31, 2024 | $117.40M | +53.7% |
| 2023 | Dec 29, 2023 | $76.40M | +24.9% |
| 2022 | Dec 30, 2022 | $61.15M | -45.8% |
| 2021 | Dec 31, 2021 | $112.83M | -21.8% |
| 2020 | Dec 31, 2020 | $144.25M | +49.0% |
| 2019 | Dec 31, 2019 | $96.80M | +8.0% |
| 2018 | Dec 31, 2018 | $89.62M | +110.2% |
| 2017 | Dec 29, 2017 | $42.63M | +53.7% |
| 2016 | Dec 30, 2016 | $27.75M | -10.7% |
| 2015 | Dec 31, 2015 | $31.07M | -7.1% |
| 2014 | Dec 31, 2014 | $33.44M | -22.0% |
| 2013 | Dec 31, 2013 | $42.88M | +314.3% |
| 2012 | Dec 31, 2012 | $10.35M | -60.0% |
| 2011 | Dec 30, 2011 | $25.85M | – |
See a number that looks wrong?